Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Apr 3;7:131–139. doi: 10.2147/IJNRD.S59937

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 Brunelli et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License

The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.

PMC Copyright notice

(A–E) Medication utilization for Tego and control cohorts. The probability of receiving an erythropoiesis-stimulating agent (ESA) and the per-session ESA dose among users for Tego and control patients in each month of the study are shown. (A and C) Unadjusted estimates; (B and D) estimates adjusted for age, race, vintage, and etiology of end-stage renal disease (model 1). Unadjusted and adjusted (model 1) estimates of the per-month probability of thrombolytic use over the entire study period are shown in panel E.

Notes: *Months in which the difference between Tego and control groups was statistically significant (P<0.05). Tego needlefree connector is manufactured by ICU Medical, Inc., San Clemente, CA, USA.